What is the Classification of Movantik?
•
3 min read
Approved by the FDA in 2014, Movantik (naloxegol) was the first once-daily oral medication in its class specifically designed to treat opioid-induced constipation (OIC). To understand **what is the classification of Movantik?**, one must look beyond traditional laxatives to its specialized function as a targeted opioid antagonist that works peripherally in the gut.
